Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
Kimberly L Spooner,1,2 Gerry Guinan,3 Saskia Koller,3 Thomas Hong,1 Andrew A Chang1,2 1Sydney Institute of Vision Science, Sydney Retina Clinic, Sydney, NSW, Australia; 2Save Sight Institute, University of Sydney, Sydney, NSW, Australia; 3So What Research, Pty Ltd, Sydney, NSW, AustraliaCorresponden...
Guardado en:
Autores principales: | Spooner KL, Guinan G, Koller S, Hong T, Chang AA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e828133016441a293bed07897b35cb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad S, et al.
Publicado: (2016) -
Prefilled syringes for intravitreal drug delivery
por: Sassalos TM, et al.
Publicado: (2019) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017) -
Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
por: Andrzej Grzybowski, et al.
Publicado: (2021) -
Safety of bilateral same-day intravitreal injections of anti-vascular endothelial growth factor agents
por: Ruão M, et al.
Publicado: (2017)